The United States Patent and Trademark Office (USPTO) granted new patent applications of Somnology, a company focused on developing mobile technologies to diagnose and monitor sleep disorders. The patent titled “System and Method for Sleep Disorder Diagnosis and Treatment” extends Somnology’s intellectual property rights including for its sleep scoring methodology.

Patrick Yam, CEO and co-founder of Somnology, says in a release, “We appreciate and thank the USPTO for their insight and acceptance in recognizing that sleep cannot remain a benign secondary health consideration. With a population exceeding 70 million people domestically affected by sleep disorders this is a health malady that deserves serious attention. Classified in 2018 as an epidemic by the Center for Disease Control, we need to be conscientious of taking constructive steps towards advancing the critical-care management of sleep disorders.”

Somnology says the acceptance of its patent applications is a testament to the experience of its chief medical officer, Melissa Lim, MD, and to the success of her medical practice as a board-certified sleep physician at Sequoia Hospital in Redwood City, Calif.

Somnology’s products include a MobileSleepDoc Pro mobile app, Plex Sleep Scanner enabling continuing monitoring, and critical-care management solution SLaaS.